Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMA ST CHRISTOPHE : revenue, balance sheet and financial ratios

SELARL PHARMA ST CHRISTOPHE is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-CHRISTOPHE-DU-LIGNERON (85670), this company of category PME shows in 2024 a net income positive of 32 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMA ST CHRISTOPHE (SIREN 907864318)
Indicator 2024 2023
Revenue N/C N/C
Net income 32 165 € 104 860 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2024, SELARL PHARMA ST CHRISTOPHE generates positive net income of 32 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 105 k€ -> 32 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

32 165 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 502%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 14%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

502.367%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

14.396%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

47.1%

Solvency indicators evolution
SELARL PHARMA ST CHRISTOPHE

Sector positioning

Debt ratio
502.37 2024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of SELARL PHARMA ST CHRISTOPHE (502.37) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
14.4% 2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch

In 2024, the financial autonomy of SELARL PHARMA ST CHRISTOPHE (14.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 236.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

236.229

Liquidity indicators evolution
SELARL PHARMA ST CHRISTOPHE

Sector positioning

Liquidity ratio
236.23 2024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good +22 pts over 2 years

In 2024, the liquidity ratio of SELARL PHARMA ST CHRISTOPHE (236.23) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMA ST CHRISTOPHE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMA ST CHRISTOPHE is estimated at 449 047 € (range 312 709€ - 671 800€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
312k€ 449k€ 671k€
449 047 € Range: 312 709€ - 671 800€
NAF 5 année 2024

Valuation method used

Net Income Multiple
32 165 € × 14.0x = 449 047 €
Range: 312 709€ - 671 800€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMA ST CHRISTOPHE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMA ST CHRISTOPHE

What is the revenue of SELARL PHARMA ST CHRISTOPHE ?

The revenue of SELARL PHARMA ST CHRISTOPHE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMA ST CHRISTOPHE profitable?

Yes, SELARL PHARMA ST CHRISTOPHE generated a net profit of 32 k€ in 2024.

Where is the headquarters of SELARL PHARMA ST CHRISTOPHE ?

The headquarters of SELARL PHARMA ST CHRISTOPHE is located in SAINT-CHRISTOPHE-DU-LIGNERON (85670), in the department Vendee.

Where to find the tax return of SELARL PHARMA ST CHRISTOPHE ?

The tax return of SELARL PHARMA ST CHRISTOPHE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMA ST CHRISTOPHE operate?

SELARL PHARMA ST CHRISTOPHE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.